| SWOG/ Support |
STUDY | R E G |
O P E N |
ARM | ACCR. GOAL |
TOTAL REGS. |
REGS. LAST 12 Month |
REGS. LAST 6 Month |
REGS. LAST 3 Month |
REGS. LAST 30 DAYS |
REGS. LAST 7 DAYS |
DATE OF FIRST REG. |
# of ACT. INSTs |
# of CURR IRBs |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SWOG | S2206-Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 1 | Y | 1 Tissue for MammaPrint testing | 960 | 1136 | 521 | 268 | 120 | 40 | 9 | 11/27/2023 | 389 | 128 |
| 1136 | 521 | 268 | 120 | 40 | 9 | |||||||||
| 2 | Y | 2 SOC Chemotherapy | 201 | 98 | 47 | 18 | 6 | 1 | 11/27/2023 | |||||
| 3 SOC Chemotherapy + Durvalumab | 195 | 89 | 46 | 14 | 4 | 0 | ||||||||
| 396 | 187 | 93 | 32 | 10 | 1 | |||||||||
| S2212-Breast, TNBC, Neoadj Chemo + Pembro | 1 | Y | 1 Carbo + Paclitaxel + Pembro -> AC + Pembro | 2400 | 782 | 396 | 217 | 104 | 37 | 8 | 09/15/2023 | 441 | 160 | |
| 2 Carbo + Docetaxel + Pembro | 783 | 392 | 219 | 106 | 38 | 7 | ||||||||
| 1565 | 788 | 436 | 210 | 75 | 15 | |||||||||
| Yes | A011801-BRST, HER2+, T-DM1+Placebo v T-DM1+Tucatinib | 1 | E | Total Registrations | 55 | 0 | 0 | 0 | 0 | 0 | 03/11/2021 | 460 | 190 | |
| 55 | 0 | 0 | 0 | 0 | 0 | |||||||||
| A012103-Breast,StgT1cN1-2/T2-4N0-2,obsvsPembrolizumab | 1 | E | Total Registrations | 63 | 27 | 17 | 10 | 7 | 2 | 08/24/2023 | 447 | 191 | ||
| 63 | 27 | 17 | 10 | 7 | 2 | |||||||||
| NRGBR002-Brst, OMBC, II-III, SoC +/- SBRT and/or SA | 1 | T | Total Registrations | 1 | 0 | 0 | 0 | 0 | 0 | 09/22/2017 | ||||
| 1 | 0 | 0 | 0 | 0 | 0 | |||||||||
| NRGBR005-Br, Stg II&IIIA, Post NAdj Chemo Br Conserv | 1 | T | Total Registrations | 7 | 0 | 0 | 0 | 0 | 0 | 06/22/2018 | ||||
| 7 | 0 | 0 | 0 | 0 | 0 | |||||||||
| No | A012303-Breast, HER2+, Shortened Adj | 1 | E | Total Registrations | 5 | 5 | 5 | 3 | 1 | 0 | 03/06/2026 | 71 | 25 | |
| 5 | 5 | 5 | 3 | 1 | 0 | |||||||||
| NRGBR009-Breast, EarlyStg, Adjuvant Chemo | 1 | E | Total Registrations | 56 | 39 | 15 | 9 | 2 | 1 | 01/31/2024 | 515 | 197 | ||
| 56 | 39 | 15 | 9 | 2 | 1 | |||||||||
| 2 | E | Total Registrations | 44 | 28 | 12 | 4 | 0 | 0 | 01/31/2024 | |||||
| 44 | 28 | 12 | 4 | 0 | 0 | |||||||||